Aerius International, Inc. (AERS) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $1.12M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAerius International, Inc. (AERS) trades at $0.005. Aerius International, Inc. provides consulting, design, construction, and financing services to marijuana operators in the United States. Market cap: $1.12M, Sector: Industrials.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for AERS: AERS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Aerius International, Inc. (AERS) Industrial Operations Profile
Aerius International, Inc. offers specialized consulting, design, construction, and financing solutions tailored for marijuana operators in the U.S. market. Based in Las Vegas, the company distinguishes itself through its focus on this niche sector within the broader industrial landscape, providing end-to-end services for cannabis businesses.
What Is the Investment Thesis for AERS?
Aerius International, Inc. presents a focused investment opportunity within the niche market of providing services to marijuana operators. The company's specialized expertise in consulting, design, construction, and financing caters directly to the needs of businesses in this rapidly growing industry. Key value drivers include the expansion of legalized marijuana markets across the U.S. and the increasing demand for professional services to navigate regulatory complexities. Potential catalysts include new state-level legalization initiatives and strategic partnerships with established cannabis companies. However, investors should be aware of risks such as evolving regulations, competition from larger consulting firms, and the company's current market capitalization of $1.12M.
Based on FMP financials and quantitative analysis
AERS Key Highlights
Aerius International, Inc. focuses on providing consulting, design, construction, and financing services, creating a diversified revenue stream within the cannabis industry.
- The company's location in Las Vegas, Nevada, provides access to a growing cannabis market and a hub for industry innovation.
- Aerius International, Inc. operates in the consulting services industry, which is expected to grow as more states legalize marijuana and businesses seek professional guidance.
- The company's negative P/E ratio of -18.22 indicates it is currently not profitable, requiring careful monitoring of its financial performance.
- The beta of -0.20 suggests the stock is less volatile than the market, but this may also reflect its limited trading activity and market capitalization.
Who Are AERS's Competitors?
AERS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| GRNQ Greenpro Capital Corp. | $7.38 | +1.23% | $13.4M | — |
| AERT Aeries Technology, Inc. | $4.02 | -15.72% | $22.2M | 77 5-pillar |
| RYOJ rYojbaba Co., Ltd. | $2.23 | -0.89% | $25.8M | 41 5-pillar |
| NORD Nordicus Partners Corporation | $2.85 | +3.26% | $56.8M | 53 5-pillar |
| RGP Resources Connection, Inc. | $2.45 | -0.81% | $85.0M | 34 5-pillar |
| FORR Forrester Research, Inc. | $8.76 | -1.79% | $159M | 46 5-pillar |
| EGG ENIGMATIG LTD | $8.54 | +14.78% | $239M | 46 5-pillar |
| SBC SBC Medical Group Holdings Incorporated | $5.60 | -10.69% | $574M | 94 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AERS's Key Strengths?
Specialized expertise in the marijuana industry.
- Comprehensive service offerings.
- Established relationships with marijuana operators.
- Focus on a niche market.
What Are AERS's Weaknesses?
Small market capitalization.
- Limited financial resources.
- Dependence on the marijuana industry.
- Negative P/E ratio.
What Are the Key Risks for AERS?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Evolving regulations in the marijuana industry could impact Aerius International's business model.
- Competition from larger consulting firms with greater resources.
- Dependence on the marijuana industry, which is subject to regulatory and market fluctuations.
- The company's small market capitalization and limited financial resources may constrain its growth potential.
What Threats Does AERS Face?
- Evolving regulations in the marijuana industry.
- Competition from larger consulting firms.
- Changes in public opinion towards marijuana.
- Economic downturn affecting the cannabis industry.
What Are AERS's Competitive Advantages?
- Specialized expertise in the marijuana industry.
- Comprehensive service offerings covering consulting, design, construction, and financing.
- Established relationships with marijuana operators.
- Focus on a niche market with high barriers to entry.
What Does AERS Do?
Aerius International, Inc., headquartered in Las Vegas, Nevada, specializes in providing comprehensive consulting, design, construction, and financing services exclusively for marijuana operators within the United States. The company was founded to address the unique challenges and opportunities present in the burgeoning cannabis industry, offering a suite of services designed to support businesses from initial concept through to operational success. Aerius International assists clients with navigating the complex regulatory landscape, designing efficient and compliant facilities, overseeing construction projects, and securing necessary financing. The company's focus on the marijuana industry allows it to develop specialized expertise and tailored solutions that meet the specific needs of its clients. Aerius aims to be a one-stop-shop for marijuana businesses seeking to establish or expand their operations.
What Products and Services Does AERS Offer?
- Provides consulting services to marijuana operators.
- Offers design services for cannabis facilities.
- Manages construction projects for marijuana businesses.
- Arranges financing for cannabis-related ventures.
- Assists clients with navigating regulatory requirements.
- Supports businesses in the marijuana industry from concept to operation.
How Does AERS Make Money?
- Generates revenue through consulting fees.
- Earns income from design and construction project management.
- Receives commissions or fees for arranging financing.
- Focuses on serving marijuana operators in the United States.
What Industry Does AERS Operate In?
Aerius International operates within the consulting services industry, specifically catering to the marijuana sector. This industry is experiencing rapid growth due to the increasing legalization of marijuana across the United States. The competitive landscape includes both specialized firms like Aerius and larger consulting companies that offer services to the cannabis industry as part of a broader portfolio. Aerius differentiates itself through its exclusive focus on marijuana operators, allowing it to develop deep expertise and tailored solutions.
Who Are AERS's Key Customers?
- Marijuana cultivators.
- Cannabis processors.
- Dispensary owners.
- Investors in the marijuana industry.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
Aerius International, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
AERS Valuation & Market Position
With a $1.12M market cap, Aerius International, Inc. sits in the micro-cap segment of the market.
Key Financial Metrics
Return on equity for Aerius International, Inc. stands at 109.1%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -1.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -25.2%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Aerius International, Inc. operates in the Consulting Services industry within the Industrials sector. It is headquartered in Las Vegas, US. AERS has traded publicly since 2010.
AERS Latest News
No recent news available for AERS.
AERS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AERS.
Price Targets
Wall Street price target analysis for AERS.
AERS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AERS; grades run from A+ (80-100) to F (below 30).
Leadership: Robert Jerhoff
CEO title
Robert Jerhoff serves as the CEO of Aerius International, Inc. Further research would be needed to provide a comprehensive overview of his career history, education, and previous roles.
Track Record: Due to the limited information available, it is not possible to assess Robert Jerhoff's track record at Aerius International, Inc. Key achievements, strategic decisions, and company milestones under his leadership are currently unknown.
AERS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Aerius International, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in this tier often have limited financial disclosure, and may not be subject to the same level of regulatory oversight. This tier is generally associated with higher risk and greater potential for volatility compared to companies listed on national exchanges due to less stringent listing requirements.
- OTC Tier: OTC Other
- Limited financial disclosure due to lower reporting requirements.
- Higher potential for fraud or manipulation due to less regulatory oversight.
- Greater price volatility due to lower trading volume and liquidity.
- Increased risk of delisting or going out of business.
- Difficulty in obtaining accurate and reliable information about the company.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the company's capital structure and potential dilution.
- Monitor trading volume and price volatility.
- Consult with a financial advisor or legal professional.
- Existence of a physical address and contact information.
- Presence of a professional website with detailed information about the company.
- Availability of some financial information, even if limited.
- Positive news coverage or industry recognition.
- Active engagement with investors and stakeholders.
What Investors Ask About Aerius International, Inc. (AERS) — Industrials
What do analysts say about AERS stock?
There is currently no available analyst coverage for Aerius International, Inc. This lack of coverage is likely due to the company's small market capitalization and its listing on the OTC Other tier.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Data provided for informational purposes only.
- Limited information available on Aerius International, Inc.
- OTC Other tier carries higher risks.